CRF Connect Logo

Advertisement

Coronary

Clinical Indications and Science

Late-Breaking Trials and Science

CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine Versus Placebo and Spironolactone Versus Placebo in Patients With Myocardial Infarction: The Results of the Colchicine Factorial

Original Broadcast: October 29, 2024

Conference: TCT 2024

Late-Breaking Trial Presenter: Sanjit S. Jolly